Xid immunodeficiency imparts increased parasite clearance and resistance to pathology in experimental Chagas' disease.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 1911532)

Published in Int Immunol on May 01, 1991

Authors

P Minoprio1, A Coutinho, S Spinella, M Hontebeyrie-Joskowicz

Author Affiliations

1: Unité d'Immunoparasitologie, Institut Pasteur, Paris, France.

Articles citing this

Oligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: a mechanism for regulation of CD4+ T-cell subsets. Proc Natl Acad Sci U S A (1994) 1.89

Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect Immun (1994) 1.38

Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3. Proc Natl Acad Sci U S A (2005) 1.28

Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzi infection in mice. Infect Immun (1997) 1.15

A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection. Proc Natl Acad Sci U S A (2006) 1.13

Differential regional immune response in Chagas disease. PLoS Negl Trop Dis (2009) 1.08

Modulation of thymocyte subsets during acute and chronic phases of experimental Trypanosoma cruzi infection. Immunology (1992) 1.00

A 24,000 MW Trypanosoma cruzi antigen is a B-cell activator. Immunology (1998) 0.91

Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice. PLoS Negl Trop Dis (2010) 0.88

Immunological activities of a Candida albicans protein which plays an important role in the survival of the microorganism in the host. Infect Immun (1993) 0.85

Depletion of peritoneal CD5+ B cells has no effect on the course of Leishmania major infection in susceptible and resistant mice. Clin Exp Immunol (1999) 0.84

Trypanosoma vivax infections: pushing ahead with mouse models for the study of Nagana. II. Immunobiological dysfunctions. PLoS Negl Trop Dis (2010) 0.83

Trypanosoma cruzi Entrance through Systemic or Mucosal Infection Sites Differentially Modulates Regional Immune Response Following Acute Infection in Mice. Front Immunol (2013) 0.83

Stimulation of B-cell lymphopoiesis by interleukin-7 leads to aggravation of murine leishmaniasis. Immunology (1995) 0.83

B-Cell Response during Protozoan Parasite Infections. J Parasitol Res (2012) 0.82

Genetic immunization converts the trypanosoma cruzi B-Cell mitogen proline racemase to an effective immunogen. Infect Immun (2009) 0.82

CD5+ B lymphocytes are the main source of antibodies reactive with non-parasite antigens in Trypanosoma congolense-infected cattle. Immunology (1997) 0.82

The use of a heterogeneously controlled mouse population reveals a significant correlation of acute phase parasitemia with mortality in Chagas disease. PLoS One (2014) 0.80

Dynamics of Lymphocyte Populations during Trypanosoma cruzi Infection: From Thymocyte Depletion to Differential Cell Expansion/Contraction in Peripheral Lymphoid Organs. J Trop Med (2012) 0.80

A parent-of-origin effect determines the susceptibility of a non-informative F1 population to Trypanosoma cruzi infection in vivo. PLoS One (2013) 0.79

Trypanosoma cruzi mitochondrial malate dehydrogenase triggers polyclonal B-cell activation. Clin Exp Immunol (2002) 0.79

Trypanosoma cruzi infection in genetically selected mouse lines: genetic linkage with quantitative trait locus controlling antibody response. Mediators Inflamm (2014) 0.78

Articles by these authors

A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol (1976) 9.11

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96

Two distinct factors are required for induction of T-cell growth. Nature (1980) 4.13

Thymus-independent B-cell induction and paralysis. Adv Immunol (1975) 3.27

The role of mitogenic lectins in T-cell triggering. Nature (1979) 3.26

Clonal growth and maturation to immunoglobulin secretion in vitro of every growth-inducible B lymphocyte. Cell (1977) 3.23

Second generation immune networks. Immunol Today (1991) 2.97

Editorial: Immune activation of B cells: evidence for 'one nonspecific triggering signal' not delivered by the Ig receptors. Scand J Immunol (1974) 2.93

Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Mol Psychiatry (2005) 2.78

Frequencies of mitogen-reactive B cells in the mouse. I. Distribution in different lymphoid organs from different inbred strains of mice at different ages. J Exp Med (1977) 2.68

Studies on T lymphocyte activation. I. Requirements for the mitogen-dependent production of T cell growth factors. Eur J Immunol (1979) 2.59

Extrathymic origin of intestinal intraepithelial lymphocytes bearing T-cell antigen receptor gamma delta. Proc Natl Acad Sci U S A (1991) 2.46

Specific T helper cells that activate B cells polyclonally. In vitro enrichment and cooperative function. J Exp Med (1980) 2.27

Localization of gamma/delta T cells to the intestinal epithelium is independent of normal microbial colonization. J Exp Med (1990) 2.23

Selective triggering of B cell subpopulations by mitogens. Eur J Immunol (1974) 2.22

Functional analysis of B cell heterogeneity. Transplant Rev (1975) 2.17

High frequency of natural autoantibodies in normal newborn mice. J Immunol (1985) 2.17

Studies on T lymphocyte activation II. The target cells for concanavalin A-induced growth factors. Eur J Immunol (1979) 2.10

Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses. J Exp Med (1974) 2.04

A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase. Nat Med (2000) 2.01

Live adult worms detected by ultrasonography in human Bancroftian filariasis. Am J Trop Med Hyg (1994) 1.90

Molecular basis of B-cell activation. I. Mitogenicity of native and substituted dextrans. Scand J Immunol (1974) 1.87

Frequencies of mitogen-reactive B cells in the mouse. II. Frequencies of B cells producing antibodies which lyse sheep or horse erythrocytes, and trinitrophenylated or nitroiodophenylated sheep erythrocytes. J Exp Med (1977) 1.84

Genetic defect in responsiveness to the B cell mitogen lipopolysaccharide. Eur J Immunol (1977) 1.83

All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes. Int Immunol (1990) 1.82

Para-aortic splanchnopleura from early mouse embryos contains B1a cell progenitors. Nature (1993) 1.82

Absolute frequencies of lipopolysaccharide-reactive B cells producing A5A idiotype in unprimed, streptococcal A carbohydrate-primed, anti-A5A idiotype-sensitized and anti-A5A idiotype-suppressed A/J mice. J Exp Med (1977) 1.80

B cell mitogenic properties of thymus-independent antigens. Nat New Biol (1973) 1.80

Genetic control of B-cell responses. I. Selective unresponsiveness to lipopolysaccharide. Scand J Immunol (1975) 1.71

In vitro activation of mouse lymphocytes in serum-free medium: effect of T and B cell mitogens on proliferation and antibody synthesis. Eur J Immunol (1973) 1.62

Differentiation of B cells: sequential appearance of responsiveness to polyclonal activators. Scand J Immunol (1974) 1.57

Occurrence of living adult Wuchereria bancrofti in the scrotal area of men with microfilaraemia. Trans R Soc Trop Med Hyg (1996) 1.56

Cloning of murine transformed cell lines in suspension culture with efficiencies near 100%. Exp Cell Res (1978) 1.55

A novel cell surface molecule on early B-lineage cells. Nature (1986) 1.55

Immunobiology of murine T. cruzi infection: the predominance of parasite-nonspecific responses and the activation of TCRI T cells. Immunol Rev (1989) 1.53

Thymic epithelium tolerizes for histocompatibility antigens. Science (1990) 1.53

The switch from IgM to IgG secretion in single mitogen-stimulated B-cell clones. J Exp Med (1978) 1.52

Evidence for a thymus-dependent form of tolerance that is not based on elimination or anergy of reactive T cells. Immunol Rev (1996) 1.50

'What if they ask how I got it?' Dilemmas of disclosing parental HIV status and testing children for HIV in Uganda. Health Policy Plan (2008) 1.50

V beta 17 gene polymorphism in wild-derived mouse strains: two amino acid substitutions in the V beta 17 region greatly alter T cell receptor specificity. Cell (1990) 1.49

Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen. J Exp Med (1976) 1.48

Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. I. Quantitation of both T- and B-cell responses. Scand J Immunol (1986) 1.46

Are lymphocytes concerned with our definition of idiotypes? Immunol Today (1993) 1.44

Continuous growth of mitogen-reactive B lymphocytes. Scand J Immunol (1975) 1.43

Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods (1998) 1.41

Psychologic predictors of duodenal ulcer healing. J Clin Gastroenterol (1996) 1.40

IgM antibodies induce the production of antibodies of the same specificity. Proc Natl Acad Sci U S A (1980) 1.40

Immunoglobulin C-gene expression. I. The commitment to IgG subclass of secretory cells is determined by the quality of the nonspecific stimuli. Eur J Immunol (1980) 1.39

Xid-associated resistance to experimental Chagas' disease is IFN-gamma dependent. J Immunol (1993) 1.38

Effects of anti-Ia serum on mitogenic responses. I. Inhibition of the proliferative response to B cell mitogen, LPS, by specific anti-Ia sera. J Immunol (1975) 1.36

In vitro induction of specific immune responses in the absence of serum: requirement for nonspecific T or B cell mitogens. Eur J Immunol (1973) 1.32

The repertoire of serum IgM in normal mice is largely independent of external antigenic contact. Eur J Immunol (1997) 1.32

Suppression of polyclonal antibody production in Trypanosoma cruzi-infected mice by treatment with anti-L3T4 antibodies. J Immunol (1987) 1.31

Role of C'3 and Fc receptors in B-lymphocyte activation. J Exp Med (1975) 1.30

Autonomous activation of B and T cells in antigen-free mice. Eur J Immunol (1986) 1.29

Mitogen-activated B-cell blasts reactive to more than one mitogen. J Exp Med (1979) 1.28

Heterogeneity of B cells: direct evidence of selective triggering of distinct subpopulations by polyclonal activators. Scand J Immunol (1976) 1.27

Parasitic load increases and myocardial inflammation decreases in Trypanosoma cruzi-infected mice after inactivation of helper T cells. Ann Inst Pasteur Immunol (1988) 1.27

Ultrasonographic assessment of the adulticidal efficacy of repeat high-dose ivermectin in bancroftian filariasis. Trop Med Int Health (1996) 1.26

Mitogenic properties of the thymus-independent antigen pneumococcal polysaccharide S3. Eur J Immunol (1973) 1.26

Reactions among IgM antibodies derived from normal, neonatal mice. Eur J Immunol (1984) 1.24

Persistence of polyclonal B cell activation with undetectable parasitemia in late stages of experimental Chagas' disease. J Immunol (1986) 1.24

Administration to mouse of endotoxin from gram-negative bacteria leads to activation and apoptosis of T lymphocytes. Eur J Immunol (1998) 1.23

Genetical control of B-cell responses. III. Requirement for functional mitogenicity of the antigen in thymus-independent specific responses. J Exp Med (1975) 1.23

Genetic and functional characterization of an antiserum to the lipid A-specific triggering receptor on murine B lymphocytes. Eur J Immunol (1978) 1.23

Antibody repertoires of normal BALB/c mice: B lymphocyte populations defined by state of activation. Immunol Rev (1986) 1.22

The theory of the 'one nonspecific signal' model for b cell activation. Transplant Rev (1975) 1.21

Population dynamics of B lymphocytes and their precursors: demonstration of high turnover in the central and peripheral lymphoid organs. J Immunol (1982) 1.21

Functional consequences of sheep red blood cell rosetting for human T cells: gain of reactivity to mitogenic factors. Eur J Immunol (1978) 1.20

Renal abnormalities in microfilaremic patients with Bancroftian filariasis. Am J Trop Med Hyg (1992) 1.20

L3T4+ T cells able to mediate parasite-specific delayed-type hypersensitivity play a role in the pathology of experimental Chagas' disease. Eur J Immunol (1987) 1.20

B-cell growth factor: distinction from T-cell growth factor and B-cell maturation factor. Proc Natl Acad Sci U S A (1982) 1.19

Genetical control of B-cell responses. IV. Inheritance of the unresponsiveness to lipopolysaccharides. J Exp Med (1975) 1.19

Derivation of hybrids between a thymoma line and spleen cells activated in a mixed leukocyte reaction. Eur J Immunol (1977) 1.19

An antiserum which recognizes lipopolysaccharide-reactive B cells in the mouse. Eur J Immunol (1978) 1.19

Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. Proc Natl Acad Sci U S A (1995) 1.18

Regulation of T cell growth factor production: arrest of TCGF production after 18 hours in normal lectin-stimulated mouse spleen cell cultures. J Immunol (1981) 1.18

Global analysis of antibody repertoires. II. Evidence for specificity, self-selection and the immunological "homunculus" of antibodies in normal serum. Eur J Immunol (1993) 1.16

Isotypic pattern of the polyclonal B cell response during primary infection by Plasmodium chabaudi and in immune-protected mice. Eur J Immunol (1987) 1.15

Lymphocytes selected in allogeneic thymic epithelium mediate dominant tolerance toward tissue grafts of the thymic epithelium haplotype. Proc Natl Acad Sci U S A (1995) 1.15

A suggested mechanism for T lymphocyte activation: implications on the acquisition of functional reactivities. Immunol Rev (1980) 1.15

A model for developmentally acquired thymus-dependent tolerance to central and peripheral antigens. Immunol Rev (1996) 1.15

Direct assessment of the adulticidal efficacy of a single dose of ivermectin in bancroftian filariasis. Trans R Soc Trop Med Hyg (1995) 1.14

Selection of VH gene repertoires: differentiating B cells of adult bone marrow mimic fetal development. Int Immunol (1990) 1.14

Clonal growth of T cells in vitro: preliminary attempts to a quantitative approach. Immunol Rev (1977) 1.14

Global analysis of antibody repertoires. 1. An immunoblot method for the quantitative screening of a large number of reactivities. Scand J Immunol (1994) 1.14

Growth and maturation of single clones of normal murine T and B lymphocytes in vitro. Cold Spring Harb Symp Quant Biol (1977) 1.13

Differential requirements for activation and growth of unprimed cytotoxic and helper T lymphocytes. Eur J Immunol (1983) 1.12

Preferential expansion of Ly-1 B and CD4- CD8- T cells in the polyclonal lymphocyte responses to murine T. cruzi infection. Int Immunol (1989) 1.12

Major Trypanosoma cruzi antigenic determinant in Chagas' heart disease shares homology with the systemic lupus erythematosus ribosomal P protein epitope. J Clin Microbiol (1990) 1.11

Humoral autoimmune response to ribosomal P proteins in chronic Chagas heart disease. Clin Exp Immunol (1991) 1.11

Further evidence for coelomic-associated B lymphocytes. Eur J Immunol (1989) 1.11

The 70-kDa heat-shock protein is a major antigenic determinant in human Trypanosoma cruzi/Leishmania braziliensis braziliensis mixed infection. Immunol Lett (1992) 1.11

Role of the humoral immune response in resistance to Theiler's virus infection. J Virol (1991) 1.11

Responsiveness of lymphoid precursors to polyclonal B-cell activators. Scand J Immunol (1975) 1.08

Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium. Eur J Immunol (1996) 1.08

The self-reactive antibody repertoire of normal human serum IgM is acquired in early childhood and remains conserved throughout life. Scand J Immunol (1996) 1.08

Intraclonal diversification in immunoglobulin isotype secretion: an analysis of switch probabilities. EMBO J (1982) 1.06